Supposed pituitary-production of human chorionic Gonadotropin induced by androgen deprivation therapy

ABSTRACT Introduction: The main cause of slightly elevated human chorionic gonadotropin (HCG) after successful treatment of male germ cell tumors is considered to be pituitary-derived HCG. It is well known that pituitary-derived HCG is frequently detected in postmenopausal women. We evaluated the s...

Full description

Bibliographic Details
Main Authors: Koji Yoshimura, Yoshiharu Nakashima, Kyohei Sugiyama, Naoki Kohei, Akitoshi Takizawa
Format: Article
Language:English
Published: Sociedade Brasileira de Urologia
Series:International Brazilian Journal of Urology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000100038&lng=en&tlng=en
_version_ 1819015153193058304
author Koji Yoshimura
Yoshiharu Nakashima
Kyohei Sugiyama
Naoki Kohei
Akitoshi Takizawa
author_facet Koji Yoshimura
Yoshiharu Nakashima
Kyohei Sugiyama
Naoki Kohei
Akitoshi Takizawa
author_sort Koji Yoshimura
collection DOAJ
description ABSTRACT Introduction: The main cause of slightly elevated human chorionic gonadotropin (HCG) after successful treatment of male germ cell tumors is considered to be pituitary-derived HCG. It is well known that pituitary-derived HCG is frequently detected in postmenopausal women. We evaluated the status of serum HCG in men with elevated gonadotropins, which were induced by androgen deprivation therapy, using commercially available assays. Materials and Methods: We enrolled 44 patients with prostate cancer, who underwent luteinizing-hormone releasing hormone agonist treatment. We measured serum follicle-stimulating hormone (FSH), serum luteinizing hormone (LH), serum total HCG, serum free HCG-β subunit, and urine total HCG 3 times per patient, on the day of treatment initiation, the next day, and 3 months after. Results: On the day after treatment initiation, serum and urine HCG was detected in 61% and 73% of patients, respectively. Markedly strong correlations were observed between serum/urine HCG and FSH/LH. In particular, receiver operating characteristic curve analysis indicated excellent area under the curve (0.977, 95% confidence interval 0.951–1.003)) for serum HCG-detectable LH. At the cutoff value of 21.07 mIU/mL for serum HCG-detectable LH, the sensitivity and specificity were 96.7% and 95.3%, respectively. Serum HCG-β was not detectable at any times in any patients. Conclusions: Suggested pituitary-derived HCG can be frequently detected in patients with elevated gonadotropins, and there is a firm association between HCG detection and gonadotropin levels.
first_indexed 2024-12-21T02:27:12Z
format Article
id doaj.art-e00bcad01d1f45778fb726a2308cde82
institution Directory Open Access Journal
issn 1677-6119
language English
last_indexed 2024-12-21T02:27:12Z
publisher Sociedade Brasileira de Urologia
record_format Article
series International Brazilian Journal of Urology
spelling doaj.art-e00bcad01d1f45778fb726a2308cde822022-12-21T19:19:01ZengSociedade Brasileira de UrologiaInternational Brazilian Journal of Urology1677-6119451384410.1590/s1677-5538.ibju.2017.0654S1677-55382019000100038Supposed pituitary-production of human chorionic Gonadotropin induced by androgen deprivation therapyKoji YoshimuraYoshiharu NakashimaKyohei SugiyamaNaoki KoheiAkitoshi TakizawaABSTRACT Introduction: The main cause of slightly elevated human chorionic gonadotropin (HCG) after successful treatment of male germ cell tumors is considered to be pituitary-derived HCG. It is well known that pituitary-derived HCG is frequently detected in postmenopausal women. We evaluated the status of serum HCG in men with elevated gonadotropins, which were induced by androgen deprivation therapy, using commercially available assays. Materials and Methods: We enrolled 44 patients with prostate cancer, who underwent luteinizing-hormone releasing hormone agonist treatment. We measured serum follicle-stimulating hormone (FSH), serum luteinizing hormone (LH), serum total HCG, serum free HCG-β subunit, and urine total HCG 3 times per patient, on the day of treatment initiation, the next day, and 3 months after. Results: On the day after treatment initiation, serum and urine HCG was detected in 61% and 73% of patients, respectively. Markedly strong correlations were observed between serum/urine HCG and FSH/LH. In particular, receiver operating characteristic curve analysis indicated excellent area under the curve (0.977, 95% confidence interval 0.951–1.003)) for serum HCG-detectable LH. At the cutoff value of 21.07 mIU/mL for serum HCG-detectable LH, the sensitivity and specificity were 96.7% and 95.3%, respectively. Serum HCG-β was not detectable at any times in any patients. Conclusions: Suggested pituitary-derived HCG can be frequently detected in patients with elevated gonadotropins, and there is a firm association between HCG detection and gonadotropin levels.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000100038&lng=en&tlng=enChorionic GonadotropinNeoplasms, Germ Cell and EmbryonalAndrogensLuteinizing Hormone
spellingShingle Koji Yoshimura
Yoshiharu Nakashima
Kyohei Sugiyama
Naoki Kohei
Akitoshi Takizawa
Supposed pituitary-production of human chorionic Gonadotropin induced by androgen deprivation therapy
International Brazilian Journal of Urology
Chorionic Gonadotropin
Neoplasms, Germ Cell and Embryonal
Androgens
Luteinizing Hormone
title Supposed pituitary-production of human chorionic Gonadotropin induced by androgen deprivation therapy
title_full Supposed pituitary-production of human chorionic Gonadotropin induced by androgen deprivation therapy
title_fullStr Supposed pituitary-production of human chorionic Gonadotropin induced by androgen deprivation therapy
title_full_unstemmed Supposed pituitary-production of human chorionic Gonadotropin induced by androgen deprivation therapy
title_short Supposed pituitary-production of human chorionic Gonadotropin induced by androgen deprivation therapy
title_sort supposed pituitary production of human chorionic gonadotropin induced by androgen deprivation therapy
topic Chorionic Gonadotropin
Neoplasms, Germ Cell and Embryonal
Androgens
Luteinizing Hormone
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000100038&lng=en&tlng=en
work_keys_str_mv AT kojiyoshimura supposedpituitaryproductionofhumanchorionicgonadotropininducedbyandrogendeprivationtherapy
AT yoshiharunakashima supposedpituitaryproductionofhumanchorionicgonadotropininducedbyandrogendeprivationtherapy
AT kyoheisugiyama supposedpituitaryproductionofhumanchorionicgonadotropininducedbyandrogendeprivationtherapy
AT naokikohei supposedpituitaryproductionofhumanchorionicgonadotropininducedbyandrogendeprivationtherapy
AT akitoshitakizawa supposedpituitaryproductionofhumanchorionicgonadotropininducedbyandrogendeprivationtherapy